Literature DB >> 21678953

Bulky, optically active P-stereogenic phosphine-boranes from pure H-menthylphosphinates.

David Gatineau1, Laurent Giordano, Gérard Buono.   

Abstract

The transformation of readily available pure-H-menthylphosphinates into chiral phosphinous acid-boranes permits the elaboration of bulky P-stereogenic secondary phosphine-boranes. Taking advantage of the synthetic potential of these compounds, a broad range of hindered P-chiral tertiary phosphine-boranes has been prepared with excellent enantiomeric excesses. The utility of bulky o-tolylphosphines was illustrated by the synthesis of a rare enantiopure phosphapalladacycle (S(P),S(P))-12.

Entities:  

Year:  2011        PMID: 21678953     DOI: 10.1021/ja2034816

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model.

Authors:  Arran Babbs; Adam Berg; Maria Chatzopoulou; Kay E Davies; Stephen G Davies; Benjamin Edwards; David J Elsey; Enrico Emer; Aude L A Figuccia; Ai M Fletcher; Simon Guiraud; Shawn Harriman; Lee Moir; Neil Robinson; Jessica A Rowley; Angela J Russell; Sarah E Squire; James E Thomson; Jonathon M Tinsley; Francis X Wilson; Graham M Wynne
Journal:  Tetrahedron       Date:  2020-01-10       Impact factor: 2.457

2.  Access to P-chiral sec- and tert-phosphine oxides enabled by Le-Phos-catalyzed asymmetric kinetic resolution.

Authors:  Haile Qiu; Qiang Dai; Jiafeng He; Wenbo Li; Junliang Zhang
Journal:  Chem Sci       Date:  2020-09-02       Impact factor: 9.825

3.  Enantioselective synthesis of P-chiral tertiary phosphine oxides with an ethynyl group via Cu(i)-catalyzed azide-alkyne cycloaddition.

Authors:  Ren-Yi Zhu; Long Chen; Xiao-Si Hu; Feng Zhou; Jian Zhou
Journal:  Chem Sci       Date:  2019-11-06       Impact factor: 9.825

4.  Pd-Catalyzed Enantioselective Hydroalkynylation of Cyclopropenes.

Authors:  Longyang Dian; Ilan Marek
Journal:  ACS Catal       Date:  2019-12-26       Impact factor: 13.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.